Fremanezumab Linked to Fewer Monthly Migraine Days

WEDNESDAY, May 16, 2018 -- For patients with episodic migraine, fremanezumab is associated with a reduction in the mean number of monthly migraine days, according to a study published in the May 15 issue of the Journal of the American Medical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news